SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-041095
Filing Date
2023-02-16
Accepted
2023-02-16 16:25:02
Documents
7
Period of Report
2023-02-16

Document Format Files

Seq Description Document Type Size
1 6-K d397876d6k.htm 6-K 18511
2 EX-99.1 d397876dex991.htm EX-99.1 45159
3 GRAPHIC g397876g0216224438613.jpg GRAPHIC 1542
4 GRAPHIC g397876g0216224438854.jpg GRAPHIC 1812
5 GRAPHIC g397876g0216224438990.jpg GRAPHIC 1709
6 GRAPHIC g397876g0216224439395.jpg GRAPHIC 3954
7 GRAPHIC g397876g0216224439554.jpg GRAPHIC 4268
  Complete submission text file 0001193125-23-041095.txt   83922
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 23638833
SIC: 2836 Biological Products, (No Diagnostic Substances)